All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Phlebology and Lymphology

Sign up for email alert when new content gets added: Sign up

Alzheimer’s disease and anticardiolipin antibodies

Author(s): Maria Regina Pereira de Godoy, Waldir Antonio Tognola, José Paulo Cipullo

Aim: The objective of this study was to assess the association between Alzheimer’s disease and elevated levels of anticardiolipin antibodies. Design and Setting: Prospective study, the levels of anticardiolipin antibodies from Alzheimer’s disease was evaluated in Neurogeriatric Ambulatory in Hospital de Base-São Jose do Rio Preto. Patients and Method: Thirty-one patients suffering from Alzheimer’s disease was evaluated. Twenty-three of the patients were female and eight male with ages ranging from 62 to 79 years old and a mean of 71.2 years. The NINCDS-ADRDA criteria were used to assess the Alzheimer’s disease. The control group was made up of 25 female and 9 male participants of a senior citizen group with ages, which varied from 62 to 80 years old. with an average of 68 years. Evaluation of the anticardiolipin antibodies was performed by means of Enzyme-Linked Immunoabsorbent Assay (ELISA) for quantitative measurement of IgG and IgM antibodies against cardiolipins in serum. Statistical analysis was made using the Fisher’s exact test, p-value < 0.05. Results: Elevated aCL levels were observed in 9 (29%) of the 31 Alzheimer’s disease patients. In the control group, 9 (26.4%) of the 34 presented with elevated levels of aCL giving a p-value of 0.58.Conclusions: This study did not evidence an association between Alzheimer’s Disease and elevated levels of aCL.